跳至主要内容
临床试验/NCT00226785
NCT00226785终止3 期

A Prospective, Multi-Centre, Randomised, Double-Blind Comparison of Intravenous Dexmedetomidine With Propofol/Midazolam for Continuous Sedation (24 Hours to 14 Days) of Ventilated Patients in Intensive Care Unit

Orion Corporation, Orion Pharma4 个研究点 分布在 2 个国家目标入组 900 人开始时间: 2005年10月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
900
试验地点
4
主要终点
Proportion of time during sedative infusion with a Richmond Agitation Sedation Scale (RASS) score within the individually-prescribed target range

研究概览

简要总结

The study aims to demonstrate that dexmedetomidine is non-inferior to current best practice sedation with propofol/midazolam and daily sedation stops, in maintaining a target depth of sedation in long-stay intensive care unit (ICU) patients, and that dexmedetomidine, compared with current best practice, reduces the length of ICU stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical need for sedation and mechanical ventilation
  • Receiving full intensive care life support
  • Expected stay in ICU of at least 48 hours (h) from time of admission
  • Expected requirement for sedation of at least 24h from time of randomisation
  • Written informed consent within 36h of ICU admission

排除标准

  • Acute severe neurological disorder
  • Acute uncompensated circulatory failure at time of randomisation
  • Severe bradycardia
  • Atrioventricular (AV) conduction block (II-III) unless pacemaker fitted
  • Severe hepatic impairment
  • Need for muscle relaxation at time of randomisation
  • Loss of hearing or vision or any condition interfering significantly with RASS assessment
  • Positive pregnancy test or currently lactating

结局指标

主要结局

Proportion of time during sedative infusion with a Richmond Agitation Sedation Scale (RASS) score within the individually-prescribed target range

Time from ICU admission to discharge

次要结局

  • Frequency of delirium
  • Frequency of organ failures and failure-free days
  • Nurse's assessment of subject communication
  • Duration of mechanical ventilation, weaning time and ventilator-free days in ICU
  • Length of total hospital stay
  • Functional recovery during hospitalisation
  • Need for rescue medication to maintain sedation
  • Frequency of critical illness polyneuropathy
  • ICU- and in-hospital survival
  • Cost of care in the ICU
  • Total cost of hospitalisation
  • Blood levels of dexmedetomidine seen with long-term treatment

研究者

申办方类型
Industry

研究点 (4)

Loading locations...

相似试验